Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study

Benzer Materyaller

• Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration
  Yazar:: Milo Gatti, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-10-01)
• Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections
  Yazar:: Milo Gatti, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-12-01)
• Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
  Yazar:: Milo Gatti, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-10-01)
• Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review
  Yazar:: Milo Gatti, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-06-01)
• Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
  Yazar:: Pasquale Maria Berrino, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-08-01)